Honglei Luo

Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial

Qi Liu, Junqiang Chen, Lin Yu et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 65 citations

Surgical Oncology, Esophageal Cancer, Gastrointestinal Oncology +8

Targeting WISP1 to sensitize esophageal squamous cell carcinoma to irradiation

Hongfang Zhang, Honglei Luo, Zhaoyang Hu et al. · Oncotarget · 2015 · 57 citations · Full text

Randomised phase III trial of concurrent chemoradiotherapy with extended nodal irradiation and erlotinib in patients with inoperable oesophageal squamous cell cancer

Shixiu Wu, Lvhua Wang, Honglei Luo et al. · European Journal of Cancer · 2018 · 27 citations

Concurrent Chemoradiotherapy, Radiation Medicine, Esophageal Cancer +10

Chemoradiotherapy with extended nodal irradiation and/or erlotinib in locally advanced oesophageal squamous cell cancer: long-term update of a randomised phase 3 trial

Congying Xie, Jing Zhao, Honglei Luo et al. · British Journal of Cancer · 2020 · 27 citations · Full text

Icotinib With Concurrent Radiotherapy vs Radiotherapy Alone in Older Adults With Unresectable Esophageal Squamous Cell Carcinoma

Honglei Luo, Wei Jiang, Li Ma et al. · JAMA Network Open · 2020 · 25 citations · Full text